benzotriazole-3-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并三唑类
• 英文名称: benzotriazole-3-carboxylic acid
• 英文别名: benzotriazole carboxylic acid；carboxybenzotriazole；1H-benzo[d][1,2,3]triazole-1-carboxylic acid；benzotriazole-1-carboxylic acid
• 化学式: C₇H₅N₃O₂
• 分子量: 163.136
• InChiKey: KYPIPCWVZKRJDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  68
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  亚磷酸三苯酯 、 benzotriazole-3-carboxylic acid 在 sodium hydroxide 作用下， 以 水 、 苯酚 为溶剂， 以80%的产率得到carboxybenzotriazole phenyl ester
  参考文献：
  名称：

  Process for production of carboxylic acid aryl esters

  摘要：

  一种生产羧酸芳基酯的工艺，包括在碱性化合物和/或水的存在下，将至少含有一个羧基的羧酸与二芳基磷酰化合物反应。羧酸芳基酯也可以通过将羧酸或其碱性盐与二芳基磷酰化合物反应来生产。

  公开号：

  US20020013491A1
• 作为产物：
  描述：

  T406石油添加剂 、 三光气 以 四氢呋喃 为溶剂， 反应 72.0h， 生成 benzotriazole-3-carboxylic acid
  参考文献：
  名称：

  [EN] NITROGEN SUBSTITUTED AROMATIC TRIAZOLES AS CORROSION CONTROL AGENTS
  [FR] TRIAZOLES AROMATIQUES SUBSTITUÉS PAR DE L'AZOTE EN TANT QU'AGENTS DE RÉGULATION DE CORROSION

  摘要：

  用于抑制与水性介质接触的金属表面腐蚀的组合物和方法，例如开放循环冷却水系统中的铜、铜合金和钢表面。在某些实施例中，将带有阴离子取代基与三唑的氮原子结合的芳香族三唑（ANST）用作腐蚀抑制剂。在其他实施例中，腐蚀抑制剂是芳香族三唑和醛的反应产物（ATA）。

  公开号：

  WO2017197047A1

文献信息

• [EN] FUSED QUINOLINE DERIVATIVE AND USE THEREOF<br/>[FR] DÉRIVÉ DE QUINOLINE FUSIONNÉE ET UTILISATION DE CELUI-CI
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2005105802A1

  公开（公告）日：2005-11-10

  The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I) wherein Rl is a hydrogen atom and the like; R2 is a hydrogen atom, a hydrocarbon group optionally having substituent(s) and the like; R3 is unsubstituted (i.e., absence), a hydrogen atom and the like; R4 and R5 are the same or different and each is a hydrogen atom, a hydrocarbon group optionally having substituent(s), and the like; R6 is (cyclic group optionally having substituent(s)) -carbonyl, and the like; R7, R8, R9 and R10 are the same or different and each is a hydrogen atom, halogen and the like; or R7 and R8, R8 and R9, and R9 and R10 may form a ring together with the adjacent carbon atoms; n is an integer of 1 to 5; --- represents unsubstituted (i.e., absence) or a single bond; and --- represents a single bond or a double bond, or a salt thereof, and the like.

  本发明旨在提供一种具有神经激肽2（NK2）受体拮抗作用的喹啉衍生物，并涉及一种由式（I）表示的化合物，其中R1是氢原子等；R2是氢原子，可选地具有取代基的碳氢基团等；R3是未取代的（即缺失），氢原子等；R4和R5相同或不同，每个是氢原子，可选地具有取代基的碳氢基团等；R6是（环状基团，可选地具有取代基）-羰基等；R7、R8、R9和R10相同或不同，每个是氢原子，卤素等；或R7和R8、R8和R9、以及R9和R10可以与相邻的碳原子一起形成环；n是1到5的整数；---表示未取代的（即缺失）或单键；---表示单键或双键，或其盐等。
• INDAZOLE DERIVATIVES AS ADENOSINE MONOPHOSPHATE DEAMINASE (AMPD) INHIBITORS FOR USE IN DIABETES AND RELATED DISEASES OF METABOLIC SYNDROME
  申请人：Ochs Raymond S.

  公开号：US20120130078A1

  公开（公告）日：2012-05-24

  Herein, we describe a method for treatment of diabetes and other disorders classified as Metabolic Syndrome. The invention provides novel AMP Deaminase (AMPD) inhibitors comprising novel indazole and benzotriazole derivatives including a phosphorous containing derivative, a carboxylic acid, or an amino acid ester prodrug. The invention also provides support for a novel mechanism of action for the existing drug metformin: direct inhibition of the enzyme AMPD. The inhibition of AMPD in turn activates AMP Kinase, known to be linked to the action of metformin. The invention also makes novel use of a double inhibitor assay allowing identification of selective AMPD inhibitors over ADA inhibitors. The new inhibitors, structurally distinct from metformin, offer selectivity that may obviate side effects known for metformin itself, providing new benefits for diabetes and Metabolic Syndrome.

  在这里，我们描述了一种治疗糖尿病和其他归类为代谢综合征的疾病的方法。该发明提供了一种新型的AMP脱氨酶（AMPD）抑制剂，包括新型的吲唑和苯并三唑衍生物，其中包括含磷衍生物、羧酸或氨基酸酯前药。该发明还支持现有药物二甲双胍的一种新颖作用机制：直接抑制AMPD酶。抑制AMPD反过来激活AMP激酶，已知与二甲双胍的作用有关。该发明还首次使用了一种双重抑制剂分析，允许识别对ADA抑制剂具有选择性的AMPD抑制剂。这些新抑制剂在结构上与二甲双胍不同，提供的选择性可能消除二甲双胍本身已知的副作用，为糖尿病和代谢综合征带来新的益处。
• CARBAMOYLBENZOTRIAZOLE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES
  申请人：Petry Stefan

  公开号：US20080287503A1

  公开（公告）日：2008-11-20

  The invention relates to carbamoylbenzotriazole derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.

  这项发明涉及一般式(I)的氨基甲酰基苯并三唑衍生物，其在描述中被定义，以及它们的药用盐和作为药物的用途。
• Composition for Sterilization Comprising W-Alkoxyperoxycarboxylic Acid
  申请人：Kawakami Masayuki

  公开号：US20080009549A1

  公开（公告）日：2008-01-10

  A peroxycarboxylic acid represented by the general formula (I): (wherein R 1 represents a substituted or unsubstituted C1-C10 alkyl group, or a substituted or unsubstituted C6-C10 aryl group, L represents a substituted or unsubstituted C2-C12 divalent linking group, or R 1 and L may combine to form a ring) and a composition comprising said peroxycarboxylic acid are provided. Said peroxycarboxylic acid can sterilize a medical apparatus such as endoscope in a short period of time and has no unpleasant smell.

  通用公式（I）表示的过氧羧酸： （其中R1表示取代或未取代的C1-C10烷基或取代或未取代的C6-C10芳基，L表示取代或未取代的C2-C12双价连接基，或R1和L可以结合形成环）以及包含所述过氧羧酸的组合物。所述过氧羧酸可以在短时间内对医疗器械如内窥镜进行灭菌，并且没有令人不愉快的气味。
• Heterocyclic compound having oxime group
  申请人：Yoshida Ichiro

  公开号：US20050227959A1

  公开（公告）日：2005-10-13

  The present invention provides a compound that has an excellent inhibitory activity on STAT6 activation and is effective against allergic diseases, and a medicinal composition thereof. According to the present invention, disclosed is the compound represented by the General Formula (I) [where R 1 and R 2 independently represent a C 1-6 alkyl group and the like that may have a hydrogen atom or a substituent; R 3 represents a C 1-6 alkyl group and the like that may have a substituent; R 4 and R 5 independent represents a hydrogen atom or a C 1-6 alkyl group and the like that may have a substituent; R 6 represents a hydrogen atom and the like; W represents —SO 2 — and the like; and X represents a sulphur atom and the like.]or a salt thereof, or a hydrate thereof.

  本发明提供了一种对STAT6激活具有优异抑制活性且对过敏疾病有效的化合物及其药物组合物。根据本发明，公开了由通式（I）表示的化合物[其中R1和R2独立地表示可能具有氢原子或取代基等的C1-6烷基基团；R3表示可能具有取代基的C1-6烷基基团等；R4和R5独立地表示可能具有取代基的氢原子或C1-6烷基基团等；R6表示氢原子等；W表示—SO2—等；X表示硫原子等]或其盐或水合物。